Cell tracking and the development of cell-based therapies: A view from the cardiovascular cell therapy research network

Martin G Rodriguez-Porcel, Marvin W. Kronenberg, Timothy D. Henry, Jay H. Traverse, Carl J. Pepine, Stephen G. Ellis, James T. Willerson, Lemuel A. Moyé, Robert D. Simari

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Cell-based therapies are being developed for myocardial infarction (MI) and its consequences (e.g., heart failure) as well as refractory angina and critical limb ischemia. The promising results obtained in preclinical studies led to the translation of this strategy to clinical studies. To date, the initial results have been mixed: some studies showed benefit, whereas in others, no benefit was observed. There is a growing consensus among the scientific community that a better understanding of the fate of transplanted cells (e.g., cell homing and viability over time) will be critical for the long-term success of these strategies and that future studies should include an assessment of cell homing, engraftment, and fate as an integral part of the trial design. In this review, different imaging methods and technologies are discussed within the framework of the physiological answers that the imaging strategies can provide, with a special focus on the inherent regulatory issues.

Original languageEnglish (US)
Pages (from-to)559-565
Number of pages7
JournalJACC: Cardiovascular Imaging
Volume5
Issue number5
DOIs
StatePublished - May 2012

Fingerprint

Cell Tracking
Cell- and Tissue-Based Therapy
Research
Cell Survival
Ischemia
Extremities
Heart Failure
Myocardial Infarction
Technology
Clinical Studies

Keywords

  • computed tomography
  • magnetic resonance imaging
  • molecular imaging
  • myocardial infarction
  • myocardium
  • positron emission tomography
  • progenitor cells
  • single photon emission computed tomography
  • stem cells

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Cell tracking and the development of cell-based therapies : A view from the cardiovascular cell therapy research network. / Rodriguez-Porcel, Martin G; Kronenberg, Marvin W.; Henry, Timothy D.; Traverse, Jay H.; Pepine, Carl J.; Ellis, Stephen G.; Willerson, James T.; Moyé, Lemuel A.; Simari, Robert D.

In: JACC: Cardiovascular Imaging, Vol. 5, No. 5, 05.2012, p. 559-565.

Research output: Contribution to journalArticle

Rodriguez-Porcel, MG, Kronenberg, MW, Henry, TD, Traverse, JH, Pepine, CJ, Ellis, SG, Willerson, JT, Moyé, LA & Simari, RD 2012, 'Cell tracking and the development of cell-based therapies: A view from the cardiovascular cell therapy research network', JACC: Cardiovascular Imaging, vol. 5, no. 5, pp. 559-565. https://doi.org/10.1016/j.jcmg.2011.12.018
Rodriguez-Porcel, Martin G ; Kronenberg, Marvin W. ; Henry, Timothy D. ; Traverse, Jay H. ; Pepine, Carl J. ; Ellis, Stephen G. ; Willerson, James T. ; Moyé, Lemuel A. ; Simari, Robert D. / Cell tracking and the development of cell-based therapies : A view from the cardiovascular cell therapy research network. In: JACC: Cardiovascular Imaging. 2012 ; Vol. 5, No. 5. pp. 559-565.
@article{f8dd5b4e3bff474dae6ad7bf5282ccd8,
title = "Cell tracking and the development of cell-based therapies: A view from the cardiovascular cell therapy research network",
abstract = "Cell-based therapies are being developed for myocardial infarction (MI) and its consequences (e.g., heart failure) as well as refractory angina and critical limb ischemia. The promising results obtained in preclinical studies led to the translation of this strategy to clinical studies. To date, the initial results have been mixed: some studies showed benefit, whereas in others, no benefit was observed. There is a growing consensus among the scientific community that a better understanding of the fate of transplanted cells (e.g., cell homing and viability over time) will be critical for the long-term success of these strategies and that future studies should include an assessment of cell homing, engraftment, and fate as an integral part of the trial design. In this review, different imaging methods and technologies are discussed within the framework of the physiological answers that the imaging strategies can provide, with a special focus on the inherent regulatory issues.",
keywords = "computed tomography, magnetic resonance imaging, molecular imaging, myocardial infarction, myocardium, positron emission tomography, progenitor cells, single photon emission computed tomography, stem cells",
author = "Rodriguez-Porcel, {Martin G} and Kronenberg, {Marvin W.} and Henry, {Timothy D.} and Traverse, {Jay H.} and Pepine, {Carl J.} and Ellis, {Stephen G.} and Willerson, {James T.} and Moy{\'e}, {Lemuel A.} and Simari, {Robert D.}",
year = "2012",
month = "5",
doi = "10.1016/j.jcmg.2011.12.018",
language = "English (US)",
volume = "5",
pages = "559--565",
journal = "JACC: Cardiovascular Imaging",
issn = "1936-878X",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Cell tracking and the development of cell-based therapies

T2 - A view from the cardiovascular cell therapy research network

AU - Rodriguez-Porcel, Martin G

AU - Kronenberg, Marvin W.

AU - Henry, Timothy D.

AU - Traverse, Jay H.

AU - Pepine, Carl J.

AU - Ellis, Stephen G.

AU - Willerson, James T.

AU - Moyé, Lemuel A.

AU - Simari, Robert D.

PY - 2012/5

Y1 - 2012/5

N2 - Cell-based therapies are being developed for myocardial infarction (MI) and its consequences (e.g., heart failure) as well as refractory angina and critical limb ischemia. The promising results obtained in preclinical studies led to the translation of this strategy to clinical studies. To date, the initial results have been mixed: some studies showed benefit, whereas in others, no benefit was observed. There is a growing consensus among the scientific community that a better understanding of the fate of transplanted cells (e.g., cell homing and viability over time) will be critical for the long-term success of these strategies and that future studies should include an assessment of cell homing, engraftment, and fate as an integral part of the trial design. In this review, different imaging methods and technologies are discussed within the framework of the physiological answers that the imaging strategies can provide, with a special focus on the inherent regulatory issues.

AB - Cell-based therapies are being developed for myocardial infarction (MI) and its consequences (e.g., heart failure) as well as refractory angina and critical limb ischemia. The promising results obtained in preclinical studies led to the translation of this strategy to clinical studies. To date, the initial results have been mixed: some studies showed benefit, whereas in others, no benefit was observed. There is a growing consensus among the scientific community that a better understanding of the fate of transplanted cells (e.g., cell homing and viability over time) will be critical for the long-term success of these strategies and that future studies should include an assessment of cell homing, engraftment, and fate as an integral part of the trial design. In this review, different imaging methods and technologies are discussed within the framework of the physiological answers that the imaging strategies can provide, with a special focus on the inherent regulatory issues.

KW - computed tomography

KW - magnetic resonance imaging

KW - molecular imaging

KW - myocardial infarction

KW - myocardium

KW - positron emission tomography

KW - progenitor cells

KW - single photon emission computed tomography

KW - stem cells

UR - http://www.scopus.com/inward/record.url?scp=84861121992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861121992&partnerID=8YFLogxK

U2 - 10.1016/j.jcmg.2011.12.018

DO - 10.1016/j.jcmg.2011.12.018

M3 - Article

C2 - 22595165

AN - SCOPUS:84861121992

VL - 5

SP - 559

EP - 565

JO - JACC: Cardiovascular Imaging

JF - JACC: Cardiovascular Imaging

SN - 1936-878X

IS - 5

ER -